Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis.

Journal of thrombosis and thrombolysis - 1 Jul 2015

Saugel Bernd, Lee Marcel, Feichtinger Stephanie, Hapfelmeier Alexander, Schmid Roland M, Siveke Jens T

Abstract excerpt

Liver cirrhosis, myeloproliferative disorders (MPDs) and prothrombotic mutations are aetiologic factors for portal vein thrombosis (PVT). The role and frequency of thrombophilic genetic risk factors in cirrhotic patients is not well established. In this case-control study, we investigated the frequency of Janus kinase 2 (JAK2) (JAK2 V617F), Factor V Leiden (FVL G1691A), and Prothrombin (G20210A) mutations in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Janus Kinase 2

Share to Liver Cirrhosis

Share to Portal Vein

Share to Prothrombin

Share to Venous Thrombosis

Source

Identifiers

PMID: 25115839
DOI: 10.1007/s11239-014-1124-z

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis.PMID 25115839Read ↗

Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma.Semantic proximity Read ↗

Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis.Semantic proximity Read ↗

Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis.Semantic proximity Read ↗

Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors.Semantic proximity Read ↗

JAK2V617F mutation in patients with portal vein thrombosis.Semantic proximity Read ↗

Novel insights into the development of portal vein thrombosis in cirrhosis patients.Semantic proximity Read ↗

Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis.Semantic proximity Read ↗

Portal vein thrombosis in patients with liver cirrhosis: Risk factors and clinical presentationSemantic proximity Read ↗

Cryptogenetic liver cirrhosis and prothrombotic mutations - A mere association?Semantic proximity Read ↗

Thrombophilia testing in patients with portal vein thrombosis.Semantic proximity Read ↗

JAK2V617F mutation in patients with splanchnic vein thrombosis.Semantic proximity Read ↗

Portal vein thrombosis: what is the role of genetics?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.